Company intelligence / Profile preview

SCL Group

Yongin-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

SCL Group (originating from Seoul Clinical Laboratories founded in 1983) is a Korean healthcare group focused on clinical laboratory diagnostics, healthcare services, and digital health/AI platforms via SCL Science; it does not develop its own therapeutic drugs but supports hospitals, pharma and labs with data, diagnostics and AI for drug discovery and clinical trial optimization[3][4][5][9].

Industry: Pathology

Partnerships

KAIST Institution for Translational Research (AI drug discovery and bio-data platform collaboration)[5]

Beyond the preview

Go deeper on SCL Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCL Group.

Explore the full profile